Synmosa Biopharma Corporation (TPEX:4114)

Synmosa Biopharma Revenue

Synmosa Biopharma had revenue of 1.63B TWD in the quarter ending March 31, 2026, with 12.45% growth. This brings the company's revenue in the last twelve months to 6.37B, up 11.44% year-over-year. In the year 2025, Synmosa Biopharma had annual revenue of 6.19B with 11.53% growth.

• Revenue (ttm): 6.37B
• Revenue Growth: +11.44%
• P/S Ratio: 2.38
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 15.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.19B	639.71M	11.53%
Dec 31, 2024	5.55B	409.05M	7.96%
Dec 31, 2023	5.14B	754.13M	17.19%
Dec 31, 2022	4.39B	1.15B	35.59%
Dec 31, 2021	3.23B	196.67M	6.47%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error